AI and Autonomy Arizona kids have a new teacher coming: artificial intelligence The 'Unbound Academy' will begin offering a 2-hour-per-day customized learning plan for students next year Rowan DunneDecember 27, 2024
Retail Apparel sizing tech expert ‘MySize’ sees 52% spike from juicy revenue predictions The Israeli company's MySizeID app enables users to measure clothing by taking a photo of it with their smartphone Rowan DunneDecember 27, 2024
Psychedelics Psychedelic YouTuber Willy Myco drops world’s first LSD synthesizing tutorial vid He travelled all the way to Pakistan to make the video without facing legal consequences Rowan DunneDecember 23, 2024
Cannabis New Jersey goes up in smoke this year with over US$1B worth of cannabis sold Many residents have been higher than those mysterious drones Rowan DunneDecember 23, 2024
Medical and Pharmaceutical RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world Rowan DunneDecember 23, 2024
Cannabis Morocco launches nation’s first cannabinoid drug for epilepsy treatment Morocco harvested 294 metric tons of legal cannabis last year Rowan DunneDecember 20, 2024
Psychedelics Psychedelic drug developer MindMed set for listing on Nasdaq Biotechnology Index MindMed's lead drug candidate is an LSD-like therapeutic used to treat anxiety Rowan DunneDecember 20, 2024
Mining Champion Iron advances Labrador mine with initial C$68.6M from Japanese partners Nippon Steel will take a 30% stake, Sojitz will hold a 19% interest and Champion will retain the remainder Rowan DunneDecember 20, 2024
Psychedelics Pope Francis lobbied for psychedelic reformation at newly disclosed Vatican meeting He met with New Testament critic Brian Muraresku in late 2021/early 2022, but nobody heard until now Rowan DunneDecember 19, 2024
Medical and Pharmaceutical Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial KB707 demonstrated a 27% objective response rate and 73% disease control rate Rowan DunneDecember 19, 2024